Formulation of a Semisolid Emulsion Containing Leptospermum scoparium Essential Oil and Evaluation of In Vitro Antimicrobial and Antibiofilm Efficacy

Abstract

Manuka oil, an essential oil derived from the Leptospermum scoparium, has been traditionally used for wound care and as a topical antibacterial, antifungal, and anti-inflammatory. However, the essential oil is not well retained at mucosal sites, such as the oral cavity, where the benefits of the aforementioned properties could be utilized toward the treatment of persistent biofilms. Within this study, L. scoparium essential oil was incorporated into a semisolid emulsion for improved delivery. The safety profile of L. scoparium essential oil on human gingival fibroblasts was determined via cell viability, cytotoxicity, and caspase activation. The minimal bactericidal concentration of L. scoparium essential oil was determined, and the emulsionʼs antibiofilm effects visualized using confocal laser scanning microscopy. L. scoparium essential oil demonstrated a lower IC₅₀ (0.02% at 48 h) when compared to the clinical control chlorhexidine (0.002% at 48 h) and displayed lower cumulative cytotoxicity. Higher concentrations of L. scoparium essential oil (≥ 0.1%) at 6 h resulted in higher caspase 3/7 activation, suggesting an apoptotic pathway of cell death. A minimal bactericidal concentration of 0.1% w/w was observed for 6 oral bacteria and 0.01% w/v for Porphyromonas gingivalis. Textural and rheometric analysis indicated increased stability of emulsion with a 1 : 3 ratio of L. scoparium essential oil: Oryza sativa carrier oil. The optimized 5% w/w L. scoparium essential oil emulsion showed increased bactericidal penetrative effects on Streptococci gordonii biofilms compared to oil alone and to chlorhexidine controls. This study has demonstrated the safety, formulation, and antimicrobial activity of L. scoparium essential oil emulsion for potential antibacterial applications at mucosal sites.

Key words

Myrtaceae - Leptospermum Scoparium - essential oil - antimicrobial - emulsion - periodontal disease

Publication History

Received: 30 January 2020

Accepted after revision: 27 November 2020

Article published online:
12 January 2021

• References

• 1 Porter NG, Wilkins AL. Chemical, physical and antimicrobial properties of essential oils of Leptospermum scoparium and Kunzea ericoides. Phytochemistry 1998; 50: 407-415
• 2 Lis-Balchin M, Hart SL, Deans SG. Pharmacological and antimicrobial studies on different tea tree oils (Melaleuca alternifolia, Leptospermum scoparium or Manuka and Kunzea ericoides or Kanuka), originating in Australia and New Zealand. Phyther Res 2000; 14: 623-629
• 3 Derraik GB. New Zealand Mānuka (Leptospermum scoparium; Myrtaceae): a brief account of its natural history and human perceptions. New Zeal Gard J 2008; 11: 25-27
• 4 Douglas MH, Van Klink JW, Smallfield BM, Perry NB, Anderson RE, Johnstone P, Weavers RT. Essential oils from New Zealand manuka: Triketone and other chemotypes of Leptospermum scoparium . Phytochemistry 2004; 65: 1255-1264
• 5 Lis-Balchin M, Hart SL. An investigation of the actions of the essential oils of Manuka (Leptospermum scoparium) and Kanuka (Kunzea ericoides), Myrtaceae on guinea-pig smooth muscle. J Pharm Pharmacol 1998; 50: 809-811
• 6 Johnston M, McBride M, Dahiya D, Owusu-Apenten R, Nigam PS. Antibacterial activity of Manuka honey and its components: an overview. AIMS Microbiol 2018; 4: 655-664
• 7 Chen CC, Yan SH, Yen MY, Wu PF, Liao WT, Huang TS, Wen ZH, David Wang HM. Investigations of kanuka and manuka essential oils for in vitro treatment of disease and cellular inflammation caused by infectious microorganisms. J Microbiol Immunol Infect 2016; 49: 104-111
• 8 Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim) 2017; 11: 72-80
• 9 Ferreira MC, Dias-Pereira AC, Branco-de-Almeida LS, Martins CC, Paiva SM. Impact of periodontal disease on quality of life: a systematic review. J Periodontal Res 2017; 52: 651-665
• 10 Cullinan MP, Seymour GJ. Periodontal disease and systemic illness: will the evidence ever be enough?. Periodontol 2000 2013; 62: 271-286
• 11 Caffesse RG, Echeverría JJ. Treatment trends in periodontics. Periodontol 2000 2019; 79: 7-14
• 12 Miastkowska M, Michalczyk A, Figacz K, Sikora E. Nanoformulations as a modern form of biofungicide. J Environ Heal Sci Eng 2020; 18: 119-128
• 13 Lu WC, Huang DW, Wang CCR, Yeh CH, Tsai JC, Huang YT, Li PH. Preparation, characterization, and antimicrobial activity of nanoemulsions incorporating citral essential oil. J Food Drug Anal 2018; 26: 82-89
• 14 Vervelle A, Mouhyi J, Del Corso M, Hippolyte MP, Sammartino G, Dohan Ehrenfest DM. [Mouthwash solutions with microencapsuled natural extracts: efficiency for dental plaque and gingivitis]. Rev Stomatol Chir Maxillofac 2010; 111: 148-151
• 15 Perry NB, Brennan NJ, Van Klink JW, Harris W, Douglas MH, McGimpsey JA, Smallfield BM, Anderson RE. Essential oils from New Zealand manuka and kanuka: chemotaxonomy of Leptospermum . Phytochemistry 1997; 44: 1485-1494
• 16 Schnitzler P, Wiesenhofer K, Reichling J. Comparative study on the cytotoxicity of different Myrtaceae essential oils on cultured Vero and RC-37 cells. Pharmazie 2008; 63: 830-835
• 17 Hayes AJ, Leach DN, Markham JL, Markovic B. In vitro cytotoxicity of Australian tea tree oil using human cell lines. J Essent Oil Res 1997; 9: 575-582 Accessed March 3, 2020 at: https://www.tandfonline.com/action/journalInformation?journalCode=tjeo20
• 18 Russo R, Corasaniti MT, Bagetta G, Morrone LA. Exploitation of cytotoxicity of some essential oils for translation in cancer therapy. eCAM 2015;
• 19 Mikus J, Harkenthal M, Steverding D, Reichling J. In vitro effect of essential oils and isolated mono- and sesquiterpenes on Leishmania major and Trypanosoma brucei. Planta Med 2000; 66: 366-368 doi:10.1055/s-2000-8548
• 20 Pavithra PS, Mehta A, Verma RS. Induction of apoptosis by essential oil from P. missionis in skin epidermoid cancer cells. Phytomedicine 2018; 50: 184-195
• 21 Benford HL, Frith JC, Auriola S, Mönkkönen J, Rogers MJ. Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol 1999; 56: 131-140
• 22 Takarada K, Kimizuka R, Takahashi N, Honma K, Okuda K, Kato T. A comparison of the antibacterial efficacies of essential oils against oral pathogens. Oral Microbiol Immunol 2004; 19: 61-64 doi:10.1046/j.0902-0055.2003.00111.x
• 23 Gibbons S. Phytochemicals for bacterial resistance–strengths, weaknesses and opportunities. Planta Med 2008; 74: 594-602
• 24 Budzyńska A, Wieckowska-Szakiel M, Sadowska B, Kalemba D, Rózalska B. Antibiofilm activity of selected plant essential oils and their major components. Polish J Microbiol 2011; 60: 35-41
• 25 Chantrapornchai W, Clydesdale FM, McClements DJ. Understanding Colors in Emulsions. In: Culver CA, Wrolstad RE. eds. Color Quality of fresh and processed Foods. Washington D. C.: ACS Publications; 2008: 364-387
• 26 Cheaburu-Yilmaz CN, Karasulu HY, Yilmaz O. Nanoscaled dispersed Systems used in Drug-Delivery Applications. In: Vasile C. ed. Polymeric Nanomaterials in Nanotherapeutics. Amsterdam, Netherlands: Elsevier; 2019: 437-468
• 27 Guvendiren M, Lu HD, Burdick JA. Shear-thinning hydrogels for biomedical applications. Soft Matter 2012; 8: 260-272
• 28 Hanning SM, Medlicott NJ. Oil-based compositions as saliva substitutes: a pilot study to investigate in-mouth retention. Int J Pharm 2016; 501: 265-270
• 29 Bruschi ML, Jones DS, Panzeri H, Gremião MPD, De Freitas O, Lara EHG. Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. J Pharm Sci 2007; 96: 2074-2089
• 30 Jones DS, Irwin CR, Woolfson AD, Djokic J, Adams V. Physicochemical characterization and preliminary in vivo efficacy of bioadhesive, semisolid formulations containing flurbiprofen for the treatment of gingivitis. J Pharm Sci 1999; 88: 592-598
• 31 Kelly HM, Deasy PB, Ziaka E, Claffey N. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis. Int J Pharm 2004; 274: 167-183
• 32 Song CY, Nam EH, Park SH, Hwang CY. In vitro efficacy of the essential oil from Leptospermum scoparium (manuka) on antimicrobial susceptibility and biofilm formation in Staphylococcus pseudintermedius isolates from dogs. Vet Dermatol 2013; 24: 404-408 e87 doi:10.1111/vde.12045
• 33 Brady A, Loughlin R, Gilpin D, Kearney P, Tunney M. In vitro activity of tea-tree oil against clinical skin isolates of meticillin-resistant and -sensitive Staphylococcus aureus and coagulase-negative staphylococci growing planktonically and as biofilms. J Med Microbiol 2006; 55: 1375-1380
• 34 Hope CK, Clements D, Wilson M. Determining the spatial distribution of viable and nonviable bacteria in hydrated microcosm dental plaques by viability profiling. J Appl Microbiol 2002; 93: 448-455
• 35 Takenaka S, Trivedi HM, Corbin A, Pitts B, Stewart PS. Direct visualization of spatial and temporal patterns of antimicrobial action within model oral biofilms. Appl Environ Microbiol 2008; 74: 1869-1875
• 36 Sparkman OD. Identification of essential oil components by gas chromatography/mass spectroscopy Robert P. Adams. J Am Soc Mass Spectrom 1997; 8: 671-672
• 37 NIST/ERA/NIH Mass Spectral Library. Software/Data Version (NIST08); NIST Standard Reference Database. Gaithersburg: National Institute of Standards and Technology; 2008
• 38 Zafar S, Coates DE, Cullinan MP, Drummond BK, Milne T, Seymour GJ. Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts. J Oral Pathol Med 2014; 43: 711-721
• 39 Carson CF, Riley TV. Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia . J Appl Bacteriol 1995; 78: 264-269
• 40 CLSI. Performance Standards for antimicrobial Disk Susceptibility Tests. 13th ed. CLSI standard MO2. Watne, PA: Clinical and Laboratory Standards Institute; 2018
• 41 Hanning SM, Yu T, Jones DS, Andrews GP, Kieser JA, Medlicott NJ. Lecithin-based emulsions for potential use as saliva substitutes in patients with xerostomia–viscoelastic properties. Int J Pharm 2013; 456: 560-568
• 42 Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000; 44: 1818-1824
• 43 Singh R, Ray P, Das A, Sharma M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother 2010; 65: 1955-1958
• 44 Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersboll BK, Molin S. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 2000; 146: 2395-2407
• 45 Vorregaard M. Comstat2–a Modern 3D image Analysis Environment for Biofilms. Denmark: Tech Univ Denmark Kongens Lyngby; 2008: 5-30